Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Chromatography. A|January 21, 2025
Strategy to mitigate aggregation during Protein A chromatography and low pH virus inactivation for a nivolumab biosimilar candidateElizabeth Pargas-Ferrer, Sum Lai Lozada Chang, Katia García, et al.
The Protein Journal|October 13, 2021
Purification and Conformational Characterization of a Novel Interleukin-2 MuteinLeina Moro-Pérez, Sum Lai Lozada-Chang, Gabriela Rivas-García, et al.
Biological Research|May 7, 2023
Conformational characterization of the mammalian-expressed SARS-CoV-2 recombinant receptor binding domain, a COVID-19 vaccineLeina Moro-Pérez, Tammy Boggiano-Ayo, Sum Lai Lozada-Chang, et al.
AMB Express|January 3, 2021
Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell linesThailin Lao-Gonzalez, Alexi Bueno-Soler, Arnelys Duran-Hernandez, et al.
Journal of Biotechnology|July 20, 2024
Oxidative refolding by Copper-catalyzed air oxidation consistently increases the homogeneity and activity of a Novel Interleukin-2 muteinSum Lai Lozada, Jose Alberto Gómez, Katherine Menéndez, et al.
Applied Microbiology and Biotechnology|July 14, 2022
Production of an anti-TNFα antibody in murine myeloma cells by perfusion cultureAlexi Bueno-Soler, Julio Palacios-Oliva, Denise Dorvignit-Pedroso, et al.
Frontiers in Bioengineering and Biotechnology|December 5, 2023
Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigensTammy Boggiano-Ayo, Julio Palacios-Oliva, Sumlai Lozada-Chang, et al.
Med (New York, N.Y.)|August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adultsMaría Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.
Vaccine|June 12, 2022
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trialsMaría Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, Meiby Rodríguez-González, et al.
Pageof 1